Search Results - "Pollak, Richard"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain by Ottoboni, Thomas, Quart, Barry, Pawasauskas, Jayne, Dasta, Joseph F, Pollak, Richard A, Viscusi, Eugene R

    Published in Regional anesthesia and pain medicine (01-02-2020)
    “…Background and objectivesObtaining consistent efficacy beyond 12–24 hours with local anesthetics, including extended-release formulations, has been a…”
    Get full text
    Journal Article
  6. 6

    HTX-011 Reduced Pain and Opioid Use After Primary Total Knee Arthroplasty: Results of a Randomized Phase 2b Trial by Lachiewicz, Paul F., Lee, Gwo-Chin, Pollak, Richard A., Leiman, David G., Hu, Jia, Sah, Alexander P.

    Published in The Journal of arthroplasty (01-10-2020)
    “…HTX-011 is an extended-release, dual-acting local anesthetic consisting of bupivacaine and low-dose meloxicam in a novel polymer that is administered by…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Efficacy and Safety of Intravenous Meloxicam in Patients With Moderate-to-Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-controlled Trial by Pollak, Richard A, Gottlieb, Ira J, Hakakian, Fardin, Zimmerman, John C, McCallum, Stewart W, Mack, Randall J, Keller, Rosemary, Freyer, Alex, Du, Wei

    Published in The Clinical journal of pain (01-10-2018)
    “…OBJECTIVE:To evaluate the analgesic efficacy and safety of a novel intravenous (IV) formulation of meloxicam (30 mg) in patients with moderate-to-severe pain…”
    Get full text
    Journal Article
  10. 10

    Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis by Pollak, Richard A

    “…Toenail onychomycosis is a common disease with limited treatment options; treatment failure and relapse are frequently encountered. Many patients experience…”
    Get full text
    Journal Article
  11. 11

    Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space by Elewski, Boni E, Pollak, Richard A, Pillai, Radhakrishnan, Olin, Jason T

    Published in Journal of drugs in dermatology (01-11-2014)
    “…To evaluate the ability of efinaconazole vehicle to reach the site of toenail onychomycosis by spreading through the subungual space between the nail plate and…”
    Get more information
    Journal Article
  12. 12

    Efficacy of Collagenase Clostridium Histolyticum Injection, a Potential Nonsurgical Intralesional Treatment Option for Plantar Fibromatosis: A Randomized, Open-Label, Dose-Ranging Study by Caporusso, Joseph, Pollak, Richard, Hernandez, David, Dalton, Shannon, Xiang, Qinfang, Vijayan, Saji, Anderson, C. James

    Published in Foot & ankle orthopaedics (01-12-2023)
    “…Category: Midfoot/Forefoot; Basic Sciences/Biologics Introduction/Purpose: Plantar fibromatosis (PFi) is characterized by collagen-containing nodules on the…”
    Get full text
    Journal Article
  13. 13

    Participant Satisfaction and Investigator Assessment of Collagenase Clostridium Histolyticum Injection as a Nonsurgical Intralesional Treatment Option for Plantar Fibromatosis by Anderson, C. James, Pollak, Richard, Dalton, Shannon, Xiang, Qinfang, Vijayan, Saji, Ortega, Luis A., Caporusso, Joseph

    Published in Foot & ankle orthopaedics (01-12-2023)
    “…Category: Midfoot/Forefoot; Basic Sciences/Biologics Introduction/Purpose: Currently, there is no safe and efficacious injectable therapy for symptomatic…”
    Get full text
    Journal Article
  14. 14

    Tolerability and Safety of Collagenase Clostridium Histolyticum Injection in Participants with Plantar Fibromatosis by Pollak, Richard, Anderson, C. James, Hernandez, David, Xiang, Qinfang, Vijayan, Saji, Ortega, Luis A., Caporusso, Joseph

    Published in Foot & ankle orthopaedics (01-12-2023)
    “…Category: Midfoot/Forefoot; Basic Sciences/Biologics Introduction/Purpose: Plantar fibromatosis (PFi) is a functionally disabling disorder characterized by…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success by Pollak, Richard A, Siu, William J Jo, Tatsumi, Yoshiyuki, Pillai, Radhakrishnan

    Published in Journal of fungi (Basel) (03-07-2015)
    “…To provide an adequate therapeutic effect against onychomycosis, it has been suggested that topical drugs should have two properties: drug permeability through…”
    Get full text
    Journal Article
  18. 18

    Opioid-Free Recovery from Bunionectomy with HTX-011, a Dual-Acting Local Anesthetic Combining Bupivacaine and Meloxicam, as the Foundation of Non-Opioid Multimodal Analgesia by Pollak, Richard, Cai, Danlin, Gan, Tong J

    “…There is a need for postoperative pain control that minimizes/eliminates opioid use during the first 72 hours following surgery, when pain is most severe…”
    Get full text
    Journal Article
  19. 19

    The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers by Marston, William A., Hanft, Jason, Norwood, Paul, Pollak, Richard

    Published in Diabetes care (01-06-2003)
    “…The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers Results of a prospective randomized trial William A. Marston ,…”
    Get full text
    Journal Article
  20. 20

    Efinaconazole Topical Solution, 10 by Pollak, Richard A.

    “…Background Toenail onychomycosis is a common disease with limited treatment options; treatment failure and relapse are frequently encountered. Many patients…”
    Get full text
    Journal Article